Stem cells are cells that can make copies of themselves and produce specialised descendants. They are part of normal growth, blood formation and tissue maintenance. The term describes several biologically different cell families, not one universal treatment. Understanding those differences is the first step toward judging any clinical proposal accurately.
What Are Stem Cells?
Most cells in the body have a defined role. A nerve cell transmits signals, a red blood cell carries oxygen and a muscle cell contracts. A stem cell is different because it retains two abilities: self-renewal, meaning it can produce another stem cell, and differentiation, meaning its descendants can become more specialised.
These abilities are essential throughout life. Blood-forming stem cells continually replace blood and immune cells. Stem cells in skin and intestinal tissue renew surfaces that experience constant wear. Other tissues have smaller resident progenitor populations that contribute to maintenance after injury.
This article explains the cells themselves. For the treatment process, administration routes and condition-specific evidence, read our separate clinical guide to what stem cell therapy is.
How Stem Cells Renew and Specialise
A stem cell can divide symmetrically, producing two stem cells, or asymmetrically, preserving one stem cell while producing a daughter cell that begins specialising. Signals from the surrounding tissue, often called the stem cell niche, influence which path it takes. Growth factors, oxygen levels, nearby immune cells and the extracellular matrix all contribute.
Potency describes the range of cell types a stem cell may form. Totipotent cells exist only at the earliest stage after fertilisation. Pluripotent cells can generate cell types from all three embryonic germ layers. Multipotent adult cells have a more limited family of possible descendants. A blood-forming stem cell, for example, produces blood lineages rather than neurons.
In many modern MSC studies, direct replacement of damaged tissue is not considered the main mechanism. Researchers increasingly focus on the signals MSCs release, including cytokines, growth factors and extracellular vesicles that may influence immune activity and the local repair environment.
The Main Stem Cell Families
| Family | Typical source | Established or studied role |
|---|---|---|
| Haematopoietic stem cells | Bone marrow, peripheral or cord blood | Established transplantation for selected blood and immune disorders |
| Mesenchymal stromal cells | Bone marrow, adipose or umbilical cord tissue | Studied for immune modulation and tissue-supporting signals |
| Tissue-specific stem cells | Skin, intestine and other organs | Normal maintenance; selected specialist applications |
| Pluripotent stem cells | Embryonic lines or reprogrammed adult cells | Research and tightly controlled clinical development |
Our guide to stem cell types explores embryonic, adult and induced pluripotent cells in greater depth. The practical point is that evidence for one cell family cannot automatically be transferred to another.
Where Clinical Stem Cells Come From
Autologous cells come from the same patient. Bone marrow aspirate and adipose tissue are common examples. This avoids donor compatibility concerns, but cell number and biological activity may be influenced by age, health and the collection method.
Allogeneic cells come from a screened donor. Donated umbilical cord tissue collected after a healthy birth is one source of MSCs. The cord would otherwise be discarded, and collection does not involve the embryo. Donor history, infectious-disease screening and traceability should be documented.
Source alone does not establish quality. Two preparations described with the same broad name can differ in donor criteria, culture conditions, passage number, viability, purity and handling. Patients comparing programmes should evaluate the complete chain from donation to administration.
Why Mesenchymal Cells Are Widely Studied
Mesenchymal stromal cells, commonly called MSCs, are investigated across musculoskeletal, immune-mediated and organ-support research. They adhere to plastic under standard culture conditions, express a recognised pattern of surface markers and can differentiate along bone, cartilage and fat lineages in laboratory testing.
Their clinical interest is largely connected to their secretome. MSCs release soluble factors and vesicles that interact with macrophages, T cells and local tissue cells. This may help explain why researchers study them even when long-term engraftment is limited. It also connects MSC science with the study of what exosomes are made of and how they are tested.
Promising biology is not the same as proven benefit for every diagnosis. Evidence ranges from established uses of blood-forming stem cells to investigational MSC applications. A responsible consultation identifies where a proposed use sits on that spectrum.
How Cell Identity and Quality Are Checked
A clinical cell preparation should be linked to a batch record. Before release, a laboratory checks identity, viable cell percentage and contamination controls. For cultured MSCs, expected identity markers include CD73, CD90 and CD105, while blood-cell markers such as CD34 and CD45 should be absent within defined limits.
- Documented donor eligibility and infectious-disease screening
- Sterility, mycoplasma and endotoxin testing
- Viability and total viable cell count
- Identity and purity markers appropriate to the product
- Culture passage and traceable processing records
- Transport, storage and administration conditions
Our checklist on how to verify MSC cell quality explains how to read these records before treatment rather than relying on a marketing description.
How Doctors Consider Stem Cell Clinical Use
A physician begins with the diagnosis, not the product. Symptoms, examination findings, imaging, laboratory tests and previous treatment establish the problem and whether standard care has been completed or should continue. The next question is whether relevant human evidence exists for a particular cell source, route and treatment goal.
At MRC Healthcare in Bangkok, records are reviewed before an international patient travels whenever possible. If a cell-based option may be reasonable, the plan identifies the source, dose, administration route, monitoring and follow-up. If evidence is limited or the medical history makes treatment unsuitable, the physician should explain that clearly.
This process turns a broad phrase such as stem cells into a specific clinical question. It also helps patients compare a measured programme with offers built around a cell count alone. Read the standards that support safer stem cell therapy before evaluating candidacy.
Medical References
- International Society for Cell & Gene Therapy. Minimal criteria for defining multipotent mesenchymal stromal cells.
- National Institutes of Health. Stem Cell Basics.
- World Health Organization. Guidance on good manufacturing practices for biological products.
- ISSCR. Guidelines for Stem Cell Research and Clinical Translation, 2021.
Ask a Specific Question About Stem Cells
Send our medical team your diagnosis and recent records. A physician can explain which cell type is relevant, what the evidence supports and whether an assessment makes sense.
Schedule a Consultation
